V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20023600 | 20010026 | 1.58 | 59.9 | Adjuvant (A) | 2017-09-16 | 2017-10-06 | FEC + DOCETAXEL | N | N | 20083396 | FEC + DOCETAXEL |
| 20023601 | 20010026 | 1.63 | 66 | Adjuvant (A) | 2017-07-19 | 2017-08-15 | FEC + DOCETAXEL | N | N | 20083396 | FEC + DOCETAXEL |
| 20023602 | 20010027 | 1.67 | 65.5 | Adjuvant (A) | 2015-10-02 | 2015-10-13 | FEC 100 + DOCETAXEL | 02 | N | 20083400 | FEC + DOCETAXEL |
| 20023603 | 20010027 | 1.63 | null | null | 2017-06-14 | 2017-06-30 | FEC + DOCETAXEL | 01 | N | 20083400 | FEC + DOCETAXEL |
| 20023604 | 20010028 | null | 77.6 | Neo-adjuvant (N) | 2013-09-13 | 2013-09-28 | FEC 100 + DOCETAXEL | N | N | 20083404 | FEC + DOCETAXEL |
| 20023605 | 20010028 | 1.7 | 70.6 | Adjuvant (A) | 2016-11-19 | 2016-11-20 | FEC 100 + DOCETAXEL | 2 | N | 20083404 | FEC + DOCETAXEL |
| 20023606 | 20010029 | 1.65 | 106 | Curative (C) | 2015-06-16 | 2015-06-16 | FEC + DOCETAXEL | N | N | 20083411 | FEC + DOCETAXEL |
| 20023607 | 20010030 | 1.8 | 53 | Adjuvant (A) | 2016-05-12 | 2016-05-28 | FEC + DOCETAXEL | N | N | 20083415 | FEC + DOCETAXEL |
| 20023608 | 20010030 | 1.71 | 61.8 | Adjuvant (A) | 2013-11-26 | 2014-01-01 | FEC + DOCETAXEL | 2 | N | 20083415 | FEC + DOCETAXEL |
| 20023609 | 20010031 | 1.65 | 97.4 | Adjuvant (A) | 2017-02-08 | 2017-02-08 | FEC + DOCETAXEL | 2 | N | 20083428 | FEC + DOCETAXEL |
| 20023610 | 20010032 | 1.59 | 58 | Not known (9) | 2017-04-04 | 2017-04-07 | FEC 100 + DOCETAXEL | 2 | N | 20083436 | FEC + DOCETAXEL |
| 20023611 | 20010033 | 1.6 | 59 | Adjuvant (A) | 2015-10-21 | 2015-11-13 | FEC + DOCETAXEL | 02 | N | 20083437 | FEC + DOCETAXEL |
| 20023612 | 20070764 | null | null | null | 2013-09-13 | 2013-09-27 | FEC 100 + DOCETAXEL | N | N | 20083438 | FEC + DOCETAXEL |
| 20023613 | 20070764 | 1.54 | 89.8 | Adjuvant (A) | null | 2013-08-04 | FEC + DOCETAXEL | N | null | 20083438 | FEC + DOCETAXEL |
| 20023614 | 20070764 | 1.62 | 74.8 | Neo-adjuvant (N) | 2014-01-02 | 2014-01-04 | FEC + DOCETAXEL | 02 | N | 20083438 | FEC + DOCETAXEL |
| 20023615 | 20070764 | 1.6 | 0 | Neo-adjuvant (N) | 2013-11-06 | 2013-10-09 | FEC + DOCETAXEL | N | N | 20083438 | FEC + DOCETAXEL |
| 20023616 | 20070764 | 1.61 | 54.65 | Adjuvant (A) | 2015-12-19 | 2015-12-30 | FEC + DOCETAXEL | N | N | 20083438 | FEC + DOCETAXEL |
| 20023617 | 20010034 | 1.7 | null | null | null | 2015-11-13 | FEC 100 + DOCETAXEL | null | N | 20083457 | FEC + DOCETAXEL |
| 20023618 | 20070765 | 1.97 | 60.35 | Adjuvant (A) | 2016-06-04 | 2016-06-24 | FEC + DOCETAXEL | N | N | 20083464 | FEC + DOCETAXEL |
| 20023619 | 20070765 | 1.76 | 87.2 | Curative (C) | 2016-08-18 | 2016-08-22 | FEC + DOCETAXEL | 2 | N | 20083464 | FEC + DOCETAXEL |
| 20023620 | 20070765 | null | 99 | null | 2013-01-21 | 2013-02-13 | FEC + DOCETAXEL | 2 | N | 20083464 | FEC + DOCETAXEL |
| 20023621 | 20070765 | 1.62 | 68 | Adjuvant (A) | 2013-05-11 | 2013-05-30 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | 02 | N | 20083464 | FEC + DOCETAXEL |
| 20023622 | 20070765 | 1.62 | 68.3 | Neo-adjuvant (N) | 2013-06-22 | 2013-06-22 | FEC + DOCETAXEL | 02 | N | 20083464 | FEC + DOCETAXEL |
| 20023623 | 20070765 | null | 103.6 | Adjuvant (A) | 2015-09-10 | 2015-09-10 | FEC 100 + DOCETAXEL | 2 | N | 20083464 | FEC + DOCETAXEL |
| 20023624 | 20010035 | null | 53.9 | Neo-adjuvant (N) | 2015-05-29 | 2015-06-04 | CYCLOPHOSPHAMIDE + DOCETAXEL + EPIRUBICIN + FLUOROURACIL | null | null | 20083476 | FEC + DOCETAXEL |
| 20023625 | 20010036 | 1.73 | 72 | Not known (9) | null | 2015-11-23 | FEC 100 + DOCETAXEL | N | N | 20083487 | FEC + DOCETAXEL |
| 20023626 | 20070766 | 1.56 | 71.7 | Adjuvant (A) | 2015-01-08 | 2015-01-27 | FEC + DOCETAXEL | Y | N | 20083488 | FEC + DOCETAXEL |
| 20023627 | 20070766 | 1.56 | 85.4 | Adjuvant (A) | 2015-02-15 | 2015-02-15 | FEC + DOCETAXEL | 02 | N | 20083488 | FEC + DOCETAXEL |
| 20023628 | 20070766 | 1.67 | 66.4 | Adjuvant (A) | 2014-06-23 | 2014-07-07 | FEC + DOCETAXEL | N | N | 20083488 | FEC + DOCETAXEL |
| 20023631 | 20010038 | 1.68 | 63.4 | Neo-adjuvant (N) | 2017-06-24 | 2017-06-27 | FEC + DOCETAXEL | 02 | Y | 20083500 | FEC + DOCETAXEL |
| 20023632 | 20010038 | 1.78 | 74.8 | Adjuvant (A) | 2015-07-06 | 2015-07-09 | FEC + DOCETAXEL | 2 | null | 20083500 | FEC + DOCETAXEL |
| 20023633 | 20010038 | 1.56 | 68.7 | Not known (9) | 2013-08-25 | 2013-08-28 | FEC + DOCETAXEL | 02 | N | 20083500 | FEC + DOCETAXEL |
| 20023634 | 20010038 | 1.64 | 122.2 | Adjuvant (A) | 2013-05-13 | 2013-05-16 | FEC + DOCETAXEL | 2 | N | 20083500 | FEC + DOCETAXEL |
| 20023635 | 20010039 | null | null | Adjuvant (A) | 2016-04-25 | 2016-05-16 | FEC + DOCETAXEL | N | N | 20083514 | FEC + DOCETAXEL |
| 20023636 | 20010039 | 1.63 | 74.5 | Adjuvant (A) | 2015-08-02 | 2015-08-09 | FEC + DOCETAXEL | 02 | Y | 20083514 | FEC + DOCETAXEL |
| 20023637 | 20010039 | 1.66 | 107.4 | Not known (9) | 2016-05-22 | 2016-05-26 | FEC + DOCETAXEL | 01 | N | 20083514 | FEC + DOCETAXEL |
| 20023638 | 20010040 | 1.72 | 90 | Adjuvant (A) | 2016-01-26 | 2016-02-06 | FEC + DOCETAXEL | N | N | 20083525 | FEC + DOCETAXEL |
| 20023639 | 20010040 | 1.7 | 76 | Curative (C) | 2017-02-24 | 2017-03-06 | FEC + DOCETAXEL | N | N | 20083525 | FEC + DOCETAXEL |
| 20023640 | 20010041 | null | 87.1 | Curative (C) | 2017-12-24 | 2018-01-05 | FEC 100 + DOCETAXEL | N | N | 20083528 | FEC + DOCETAXEL |
| 20023641 | 20010042 | 1.71 | 55.8 | Adjuvant (A) | 2017-06-04 | 2017-06-15 | FEC + DOCETAXEL | 2 | N | 20083533 | FEC + DOCETAXEL |
| 20023642 | 20070771 | 1.63 | 68.4 | Adjuvant (A) | 2014-01-20 | 2014-01-27 | FEC + DOCETAXEL | 2 | N | 20083535 | FEC + DOCETAXEL |
| 20023643 | 20010043 | 1.55 | 95 | Adjuvant (A) | 2016-03-01 | 2016-03-01 | FEC + DOCETAXEL | 02 | N | 20083544 | FEC + DOCETAXEL |
| 20023644 | 20010043 | 1.65 | 57 | Adjuvant (A) | 2014-12-19 | 2014-12-24 | FEC + DOCETAXEL | 02 | N | 20083544 | FEC + DOCETAXEL |
| 20023645 | 20010044 | 1.62 | 72.9 | Adjuvant (A) | 2014-12-23 | 2015-01-01 | FEC + DOCETAXEL | N | N | 20083548 | FEC + DOCETAXEL |
| 20023646 | 20010045 | 1.71 | 71.95 | Neo-adjuvant (N) | 2014-01-08 | 2014-01-09 | FEC + DOCETAXEL | N | N | 20083551 | FEC + DOCETAXEL |
| 20023647 | 20010046 | 1.63 | null | Palliative (P) | 2016-10-23 | 2016-11-28 | FEC + DOCETAXEL | 2 | N | 20083552 | FEC + DOCETAXEL |
| 20023648 | 20070773 | 1.65 | 56 | Neo-adjuvant (N) | 2013-04-23 | 2013-04-27 | FEC + DOCETAXEL | 02 | null | 20083553 | FEC + DOCETAXEL |
| 20023649 | 20070773 | 1.44 | 65.6 | Disease modification (D) | 2014-05-08 | 2014-05-20 | FEC + DOCETAXEL | 02 | null | 20083553 | FEC + DOCETAXEL |
| 20023650 | 20010047 | 1.54 | 64.4 | Neo-adjuvant (N) | 2016-07-22 | 2016-09-24 | FEC + DOCETAXEL | N | N | 20083559 | FEC + DOCETAXEL |
| 20023651 | 20010047 | 1.65 | 69.9 | Adjuvant (A) | null | 2013-10-10 | FEC + DOCETAXEL | N | N | 20083559 | FEC + DOCETAXEL |